2713-28-2Relevant academic research and scientific papers
TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE
-
Paragraph 0522; 0523, (2016/12/22)
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
ORGANIC COMPOUNDS
-
Page/Page column 94, (2014/05/24)
Novel benzofuran derivatives are disclosed. The derivatives have S1P1 receptor activity and/or disease modifying activity and find use in the treatment of conditions or diseases associated with the immune, vascular and nervous systems in animals and/or humans
CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS
-
, (2012/05/04)
A compound of general formula I their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical
Mild and efficient oxy-iodination of alkynes and phenols with potassium iodide and tert-butyl hydroperoxide
Rajender Reddy,Venkateshwar,Uma Maheswari,Santhosh Kumar
supporting information; experimental part, p. 2170 - 2173 (2010/06/14)
An efficient synthesis of 1-iodoalkynes and iodophenols was easily achieved by employing simple KI and TBHP. The reaction does not involve the use of a metal and base combination. A variety of substituted alkynes and phenols were prepared with good to excellent yield.
NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE
-
Page/Page column 26, (2009/09/26)
The present invention relates to a compound represented by formula (I), which has a GPR120 agonist action and thus is useful for treatment of diabetes mellitus or hyperlipidemia, or a pharmaceutically acceptable salt thereof. In the formula, (AA) represents a phenyl or the like, which may be substituted with a lower alkoxy group or the like; (BB) represents a divalent group or the like, derived by removal of two hydrogen atoms from a benzene which may be substituted with a halogen atom or the like; X represents a spacer having a main chain composed of 1-8 carbon atoms wherein 1-3 carbon atoms in the main chain may be substituted with an oxygen atom or the like; and Y represents a hydrogen atom or the like.
Liquid crystal compounds and optically active compounds
-
, (2008/06/13)
A compound usefull for liquid crystal component which is represented by the following formulas (1), (2), (3), or (4) ;, R1 -X1 -A1 -( A2 )n-Y1 -A3 -X2 -R2 (1), R1 -X1 -( A3 -Y1 )N-A1 -A2 -X2 -R2 (2), R3 -X1 -A4 -Y1 -A3 -X2 -R4 (3), R3 -X1 -A5 -Y1 -A1 -A2 -X2 -R4 (4), wherein R1 ,R2 ,R3 and R4 are C1 18 alkyl groups; X1 and X2 is -, O, S, -C≡C- or divarent groups such as COO, OCO, CH2 O or OCH2
